Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor.

Farhatullah Syed, D Sherris, Ralf Paus, S Varmeh, S Singh, PP Pandolfi, Ardeshir Bayat

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor.'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science